FLCCC and Allied Publications
- WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, most recently amended, 64th WMA General Assembly, Fortaleza, Brazil, October 2013.
- MATH+ protocol for the treatment of SARS-CoV-2 infection: The scientific rationale Paul E. Marik, Pierre Kory, Joseph Varon, Jose Iglesias & G. Umberto Meduri (published in the Taylor & Francis Online, August 18, 2020).
- SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’ (published in the BMJ Open Respiratory Research, September 22, 2020).
- COVID-19: A Clinician’s Perspective: A master-class comprehensive review by Dr. Paul Marik of scientific insights into the origin, replication, transmission, infectivity, pathophysiology, and treatment of COVID-19. (USA, September 25, 2020).
- Information about the MATH+ protocol and the medicines used can be found in our peer-reviewed paper Clinical and Scientific Rationale for the MATH+ Hospital Treatment Protocol for COVID-19 (published in the Journal of Intensive Care Medicine, December 2020).
- Our review of Ivermectin: Review of the Emerging Evidence Supporting the Use of Ivermectin in the Prophylaxis and Treatment of COVID-19 – November 2020. also see our Ivermectin in COVID-19 section.
- A “Summary of the Evidence for Ivermectin in COVID-19”: FLCCC Alliance Review: Ivermectin in prevention and treatment of COVID-19.
- Masks! – Clearing Up the Confusion When to wear them, when not to wear them, that is the question. An essay by Dr. Pierre Kory. (published January 5, 2021).
- Global trends in clinical studies of ivermectin in COVID-19: Dr. Satoshi Ōmura, co-author of the newly published paper, “Global trends in clinical studies of ivermectin in COVID-19” was one of the four researchers from Kitasato University in Tokyo, Japan who received the Nobel Prize in Physiology or Medicine in 2015 for their discovery of ivermectin. (published April 5, 2021).
- Our peer-reviewed paper on Ivermectin: Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. (published in the American Journal of Therapeutics, May 2021 ).
- Bryant, Lawrie et al Meta-analysis of Ivermectin: Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. (American Journal of Therapeutics, June 2021). Authors’ Update
- Andrew Hill, et al: Meta-analysis of ivermectin by the WHO research team: Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 Infection. (Published by Oxford University Press on behalf of Infectious Diseases Society of America, July 2021).
- Marik, Paul, et al: Researching the different clinical stages of COVID 19 and pinpointing the treatment needed for each stage: A Scoping Review of the Pathophysiology of COVID-19. (Published by The International Journal of Immunopathology & Pharmacology, September 2021).
